Bayer

illustration of two people shaking hands for a merger or acquisitions deal
Biotech

Bayer buys Perfuse in $2.4B deal for ph. 2 eye disease prospect

The buyout, which includes $2.15 billion in milestones, will give Bayer control of an eye disease implant that improved outcomes in phase 2 trials.
Nick Paul Taylor May 6, 2026 7:20am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders

Apr 3, 2026 8:30am
Constellation Orion

Oryon shines out of stealth with $21M to fight Parkinson's

Mar 23, 2026 5:00am
pipeline pipes RD research

Bayer ditches 1 AAV gene therapy from Pompe disease pair

Mar 4, 2026 9:59am
An arrow incrementally going up stairs before pointing straight up Blue background

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

Feb 5, 2026 12:15pm
Pulmonologist showing CT scan of lungs woman patient being examined in the background

Bayer strikes deal with Attralus for 2 diagnostic tracers

Jan 12, 2026 10:00am